Kenta Biotech AG
  • Home
  • Shop
  • Events
  • Courses
  • Services
  • Pricing
  • Company
    • Blog
    • Success Stories
    • About Us
  • Appointment
  • Contact us
  • 0
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
Kenta Biotech AG
  • 0
    • Home
    • Shop
    • Events
    • Courses
    • Services
    • Pricing
    • Company
      • Blog
      • Success Stories
      • About Us
    • Appointment
    • Contact us
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
  1. Products
  2. Serum for Cell Culture and IgG
Public Pricelist
Public Pricelist
Sort By: Featured
Featured Newest Arrivals Name (A-Z) Price - Low to High Price - High to Low

Serum for Cell Culture and IgG

[0089-FBS002-T] FBS - Tet-Free Fetal Bovine Serum - 500 ml
FBS - Tet-Free Fetal Bovine Serum - 500 ml
974.00 € 974.0 EUR
[0089- FBS002-X-250ml] FBS - EXOSOME FREE FETAL BOVINE SERUM668,250 ml
FBS - EXOSOME FREE FETAL BOVINE SERUM668,250 ml
1,202.00 € 1202.0 EUR
[0089- FBS002-X-100mL] FBS - EXOSOME FREE FETAL BOVINE SERUM, 100 ml
FBS - EXOSOME FREE FETAL BOVINE SERUM, 100 ml
520.60 € 520.6 EUR
[0568-P101] Exosome Isolation Test   (for serum & plasma)-10 rxn
Exosome Isolation Test (for serum & plasma)-10 rxn
649.00 € 649.0 EUR
[0568-P101L] Exosome Isolation Test   (for serum & plasma), 40 rxn
Exosome Isolation Test (for serum & plasma), 40 rxn
2,058.00 € 2058.0 EUR
[0568-P101S] Exosome Isolation Test   (for serum & plasma), 2rxn
Exosome Isolation Test (for serum & plasma), 2rxn
329.00 € 329.0 EUR
[0322-EQ806A-1] ExoQuick® Exosome Isolation and RNA Purification Test (for Serum & Plasma) - 20 Preps
ExoQuick® Exosome Isolation and RNA Purification Test (for Serum & Plasma) - 20 Preps
766.50 € 766.5 EUR
[0322-EQULTRA-20A-1] ExoQuick ULTRA EV Isolation Test for Serum and Plasma - 20 Reactions
ExoQuick ULTRA EV Isolation Test for Serum and Plasma - 20 Reactions
805.50 € 805.5 EUR
[0322-EQPL10A-1] ExoQuick PLUS Exosome Purification Test - for serum and plasma, 10rxn
ExoQuick PLUS Exosome Purification Test - for serum and plasma, 10rxn
783.00 € 783.0 EUR
[0714-ES05] Equine Serum Non Sterile (1x500ml) - 500 ml
Equine Serum Non Sterile (1x500ml) - 500 ml
697.00 € 697.0 EUR
[0047-DF-190/500] Donor Foal Serum - 500ml
Donor Foal Serum - 500ml
326.00 € 326.0 EUR
[0513-DAG124] Dog Serum, 100 ml
Dog Serum, 100 ml
2,425.00 € 2425.0 EUR
[0173-7D2442] Determine Syphilis Serum Plasma - 30 tests/Test
Determine Syphilis Serum Plasma - 30 tests/Test
271.00 € 271.0 EUR
[1000-JB-CS-10] Cyprinus carpio Serum -10 mL
Cyprinus carpio Serum -10 mL
785.00 € 785.0 EUR
[0118-70R-15097] Chicken Serum Albumin antibody, 0.1 mG.
Chicken Serum Albumin antibody, 0.1 mG.
759.00 € 759.0 EUR
[0118- 60R-1130] Chicken Serum Albumin antibody (HRP),0.1 mG.
Chicken Serum Albumin antibody (HRP),0.1 mG.
756.00 € 756.0 EUR
[0015-20008-5] Mouse IgG, purified (serum non-immune, isotype control), 5mG.
Mouse IgG, purified (serum non-immune, isotype control), 5mG.
405.00 € 405.0 EUR
[0015-20008-25] Mouse (non-immune) Serum IgG, purified,  25mG.
Mouse (non-immune) Serum IgG, purified, 25mG.
585.00 € 585.0 EUR
[0100-E-90SAA] Mouse (Serum Amyloid A) SAA ELISA Test - 96-wells plate
Mouse (Serum Amyloid A) SAA ELISA Test - 96-wells plate
557.00 € 557.0 EUR
[0015-JEV14-M] Monoclonal Anti-Rec. Japanese Encephalitis Virus (JEV) envelop protein E (JEV-EP), Antiserum Unpurified - 100ul
Monoclonal Anti-Rec. Japanese Encephalitis Virus (JEV) envelop protein E (JEV-EP), Antiserum Unpurified - 100ul
585.00 € 585.0 EUR
  • 2
  • 3
  • 4
  • 5
  • 6

Clear Filters



Respiratory syncytial virus (RSV) infections are the most common cause of hospitalization in early childhood, accounting for 57 000 to 120 000 hospitalizations each year in the United States. RSV is causing annual epidemics of bronchiolitis and pneumonia worldwide. In most cases the infection with RSV heals without sequelae, yet RSV infection can cause lung function deterioration and in some circumstances, years of recurrent wheezing or asthma may ensue. Overall RSV accounts for an estimated2% of the hospitalization rate among infants less than 1 year of age. This rate increases 4–5-fold among high-risk patients such as premature infants and those with chronic lung disease or complicated congenital heart disease.


Currently there is only one possibility to prevent infections of at-risk patients with RSV, namely immuno-prophylaxis with palivizumab/Synagis, marketed by MedImmune. However, the response to palivizumab is variable among individuals, and sometimes palivizumab fails to prevent RSV infections effectively.


Due to the lack of better antibodies, lack of effective anti-viral treatment and lack of an effective preventive vaccine for RSV, there is a substantial medical need for more efficacious prophylactic immunizations, e.g. by antibody.


Kenta Biotech had developed a fully human monoclonal antibody (KBRV201) derived from B-cells of a human donor. KBRV201 is of the human IgG1 isotype with specificity and very high affinity for the F-protein of human respiratory syncytial virus (hRSV). KBRV201 has been tested for recognition and neutralization of hRSV strains -A, -B and –Long, and KBRV201 could neutralize in vitro all strains tested with higher efficacy than other anti-F-protein mAb.




KBRV201 successfully recognizes 22 clinical isolates from children infected with RSV, including one isolate with a mutated F-protein. Overall KBRV201 has demonstrated superiority in every experiment performed, and KBRV201 is currently undergoing extensive testing in animal models.

14009 NW Harbor Ln, Portland, OR 97229, USA.


Follow us
Copyright © 2025 Kenta Biotech AG
English (UK) English (US)